Anemia Treatment Market By Anemia (Iron Deficiency, Sickle Cell, Pernicious, Thalassemia, and Hemolytic), By Drug (Bone Marrow Stimulants, Gene Therapy, Iron Chelating Agents, Corticosteroids, Supplements, and Immunotherapy), and By Distribution Channel (Retail Pharmacies, E-Commerce, and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Description

The report analyzes and forecasts the anemia treatment market on a global and regional level. The study offers past data from 2017 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The report gives brief information about the drivers and restraints of the anemia treatment market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the anemia treatment market on a global level.

In order to give a transparent comprehensive view of the anemia treatment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the anemia treatment market is divided on the basis of anemia, drug, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players of global anemia treatment market are Pfizer, Johnson and Johnson, Novartis, Roche, Amgen, Bayer, Glaxosmithkline, Teva Pharmaceuticals, Novo Nordisk, CSL, AMAG Pharmaceuticals, Rockwell Medicines, Akebia Therapeutics, and Vifor Pharma.

This report segments the global anemia treatment market into:

Global Anemia Treatment Market: Anemia Analysis

• Iron Deficiency Anemia
• Hemolytic Anemia
• Sickle Cell Anemia
• Pernicious Anemia
• Thalassemia Anemia

Global Anemia Treatment Market: Drug Analysis

• Bone Marrow Stimulants
• Gene Therapy
• Iron Chelating Agents
• Corticosteroids
• Supplements
• Immunotherapy

Global Anemia Treatment Market: Distribution Channel Analysis

• Retail Pharmacies
• Hospital Pharmacies
• E-Commerce

Global Anemia Treatment Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Anemia Treatment Market, 2017-2025 (USD Million)
  • 2.2. Global Anemia Treatment Market: Snapshot
•  
• Chapter 3. Anemia Treatment Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Anemia Treatment Market drivers: impact analysis
    • 3.2.2. High Rate Of Nutritional Deficiency
    • 3.2.3. Growing Baby Blooming Population
    • 3.2.4. Increase In Chronic Diseases And Disorders
    • 3.2.5. Government initiatives for improving the healthcare facilities in developing countries
    • 3.2.6. The advanced growing research and development in the field of anemia medications
  • 3.3. Market restraints
    • 3.3.1. Global Anemia Treatment Market Restraints: Impact analysis
    • 3.3.2. The high cost of dietary supplements
    • 3.3.3. Medications of anemia drugs have adverse effects on the human body
    • 3.3.4. Lack of awareness
  • 3.4. Opportunities
    • 3.4.1. Evolving market
    • 3.4.2. Advanced technology
    • 3.4.3. Growing nutritional deficiency
    • 3.4.4. Growing distribution channels
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Anemia
    • 3.6.2. Market attractiveness analysis, by Drug
    • 3.6.3. Market attractiveness analysis, by Distribution Channel
    • 3.6.4. Market attractiveness analysis, by Region
•  
• Chapter 4. Global Anemia Treatment Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Anemia Treatment Market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New instruments launch
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
•  
• Chapter 5. Global Anemia Treatment Market - Anemia Analysis
  • 5.1. Global Anemia Treatment Market: Anemia overview
    • 5.1.1. Global Anemia Treatment Market Share, by anemia, 2018 and 2025
  • 5.2. Iron Deficiency Anemia
    • 5.2.1. Anemia Treatment Market for Iron Deficiency Anemia, 2017-2025 (USD Million)
  • 5.3. Hemolytic anemia
    • 5.3.1. Global Anemia Treatment Market for Hemolytic Anemia, 2017-2025 (USD Million)
  • 5.4. Sickle Cell Anemia
    • 5.4.1. Global Anemia Treatment Market for Sickle Cell Anemia, 2017-2025 (USD Million)
  • 5.5. Pernicious Anemia
    • 5.5.1. Global Anemia Treatment Market for Pernicious Anemia, 2017-2025 (USD Million)
  • 5.6. Thalassemia Anemia
    • 5.6.1. Global Anemia Treatment Market for Thalassemia Anemia, 2017-2025 (USD Million)
•  
• Chapter 6. Global Anemia Treatment Market - Drug Analysis
  • 6.1. Global Anemia Treatment Market: Drug overview
    • 6.1.1. Global Anemia Treatment Market Share, by drug, 2018 and 2025
  • 6.2. Bone Marrow Stimulants
    • 6.2.1. Global Anemia Treatment Market for Bone Marrow Stimulants, 2017-2025 (USD Million)
  • 6.3. Gene Therapy
    • 6.3.1. Global Anemia Treatment Market for Gene Therapy, 2017-2025 (USD Million)
  • 6.4. Iron chelating agents
    • 6.4.1. Global Anemia Treatment Market for Iron Chelating Agent, 2017-2025 (USD Million)
  • 6.5. Corticosteroids
    • 6.5.1. Global Anemia Treatment Market for Corticosteroids, 2017-2025 (USD Million)
  • 6.6. Supplements
    • 6.6.1. Global Anemia Treatment Market for Supplements, 2017-2025 (USD Million)
  • 6.7. Immunotherapy
    • 6.7.1. Global Anemia Treatment Market for Immunotherapy, 2017-2025 (USD Million)
•  
• Chapter 7. Global Anemia Treatment Market - Distribution Channel Analysis
  • 7.1. Global Anemia Treatment Market: Distribution channel overview
    • 7.1.1. Global Anemia Treatment Market Share, by distribution channel, 2018 and 2025
  • 7.2. Retail pharmacies
    • 7.2.1. Global Anemia Treatment Market for Retail pharmacies, 2017-2025 (USD Million)
  • 7.3. E-commerce
    • 7.3.1. Global Anemia Treatment Market for E-Commerce, 2017-2025 (USD Million)
  • 7.4. Hospital pharmacies
    • 7.4.1. Global Anemia Treatment Market for hospital pharmacies, 2017-2025 (USD Million)
•  
• Chapter 8. Global Anemia Treatment Market - Regional Analysis
  • 8.1. Global Anemia Treatment Market: Regional overview
    • 8.1.1. Global Anemia Treatment Market Share, by region, 2018 and 2025
  • 8.2. North America
    • 8.2.1. North America Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
    • 8.2.2. North America Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
    • 8.2.3. North America Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.2.4.2. The U.S. Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.2.4.3. The U.S. Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.2.5. Canada
      • 8.2.5.1. Canada Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.2.5.2. Canada Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.2.5.3. Canada Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
    • 8.3.2. Europe Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
    • 8.3.3. Europe Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. UK Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.3.4.2. UK Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.3.4.3. UK Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.3.5. Germany
      • 8.3.5.1. Germany Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.3.5.2. Germany Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.3.5.3. Germany Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. France Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.3.6.2. France Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.3.6.3. France Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.3.7. Rest of Europe
      • 8.3.7.1. Rest of Europe Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.3.7.2. Rest of Europe Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.3.7.3. Rest of Europe Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
    • 8.4.2. Asia Pacific Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
    • 8.4.3. Asia Pacific Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. China Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.4.4.2. China Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.4.4.3. China Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.4.5.2. Japan Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.4.5.3. Japan Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.4.6. India
      • 8.4.6.1. India Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.4.6.2. India Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.4.6.3. India Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.4.7. Rest of Asia Pacific
      • 8.4.7.1. Rest of Asia Pacific Anemia Treatment Market Revenue, by country, 2017-2025 (USD Million)
      • 8.4.7.2. Rest of Asia Pacific Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.4.7.3. Rest of Asia Pacific Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.4.7.4. Rest of Asia Pacific Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
    • 8.5.2. Latin America Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
    • 8.5.3. Latin America Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.5.4.2. Brazil Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.5.4.3. Brazil Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
      • 8.5.5.2. Rest of Latin America Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
      • 8.5.5.3. Rest of Latin America Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Anemia Treatment Market Revenue, by country, 2017-2025 (USD Million)
    • 8.6.2. The Middle East and Africa Anemia Treatment Market Revenue, by anemia, 2017-2025 (USD Million)
    • 8.6.3. The Middle East and Africa Anemia Treatment Market Revenue, by drug, 2017-2025 (USD Million)
    • 8.6.4. The Middle East and Africa Anemia Treatment Market Revenue, by distribution channel, 2017-2025 (USD Million)
•  
• Chapter 9. Company Profile
  • 9.1. Pfizer
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. Johnson and Johnson
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Roche
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Teva Pharmaceutical
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. Novo Nordisk
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Developments
  • 9.6. AMAG Pharmaceuticals
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Developments
  • 9.7. Rockwell Medicines
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Developments
  • 9.8. CSL
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Developments
  • 9.9. Akebia Therapeutics
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Developments
  • 9.10. Vifor Pharma
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategy
    • 9.10.5. Recent Developments

Methodology

Free Analysis

Anemia is caused by the lack of red blood cells or hemoglobin in the human body. Red blood cells are responsible for carrying oxygen from lungs to rest of the body. Anemia symptoms include weakness, feeling tired, shortness of breath, and restrictions in physical activities, which may vary according to age, altitude, smoking habits, sex, and pregnancy status. Anemia, if left untreated, may even cause death. The main cause of anemia is various nutritional and non-nutritional factors, such as infectious diseases like malaria and tuberculosis.

According to the WHO, in 2018, about 56% of people globally were affected by anemia. Anemia can be effectively treated with a proper treatment method. The high rate of nutritional deficiency is among the most important driving factors of the anemia treatment market. According to the WHO, 50% of anemic cases are caused by iron deficiency due to low iron intake. Growing baby booming population and increasing chronic diseases and disorders are fuelling the anemia treatment market. Improper nutritional diet in underdeveloped countries also contributes to this market. According to the World Bank, anemia is the 8th major disease among young girls and women. Various government initiatives for improving the healthcare facilities in developing countries are also estimated to drive the anemia treatment market in the future. The continuous research and development activities related to anemia drugs and increasing anemia awareness in developing and undeveloped countries are estimated to create new growth opportunities in the anemia treatment market over the forecast period. However, medications of anemia drugs have adverse effects on the human body, which may hamper this market. For instance, patients with diabetes consuming iron for anemia may increase heart diseases among patients.

The anemia treatment market is fragmented on the basis of anemia, drug, and distribution channel. By anemia, the anemia treatment market includes iron deficiency, sickle cell, pernicious, thalassemia, and hemolytic. By drug, the market is divided into corticosteroids, gene therapy, bone marrow stimulants, iron chelating agents, immunotherapy, and supplements. On the basis of distribution channel, the anemia treatment market comprises e-commerce, hospital pharmacies, and retail pharmacies.

North America is projected to dominate the anemia treatment market globally, owing to the early introduction of highly developed treatment options, increasing nutritional deficiency due to changing lifestyle, and constant introduction of favorable reimbursement policies. The Asia Pacific anemia treatment market is anticipated to show a notable growth rate over the forecast time period.

Some key players of global anemia treatment market are Pfizer, Johnson and Johnson, Novartis, Roche, Amgen, Bayer, GlaxoSmithKline, Teva Pharmaceuticals, Novo Nordisk, CSL, AMAG Pharmaceuticals, Rockwell Medicines, Akebia Therapeutics, and Vifor Pharma.